Can a nuclear medicine scan (MIBI-kidney) tell us if a mass in the kidney is cancer?
Not Applicable
- Conditions
- Kidney cancerCancerMalignant neoplasm of kidney
- Registration Number
- ISRCTN12572202
- Lead Sponsor
- niversity College London
- Brief Summary
2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36693694/ (added 25/01/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
1. Age >18 years, and <95 years of age
2. Any gender
3. cT1 renal tumour >2cm identified on cross sectional imaging (CT or MRI) of unknown histological diagnosis
4. Patients undergoing tumour biopsy or surgery as part of routine care
5. Willing and able to provide informed consent.
Exclusion Criteria
1. Females who are pregnant, planning pregnancy or breastfeeding
2. Concurrent and/or recent involvement in other research that is likely to interfere with the intervention within 3 months of study enrolment
3. Multiple comorbidities which would make trial participation difficult (e.g. burden of an additional hospital visit).
4. Allergy to 99mTc Sestamibi
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method